Advertisement
U.S. Markets open in 7 hrs 57 mins

Aptahem AB (publ) (APTA.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
1.6400-0.0100 (-0.61%)
At close: 04:20PM CEST

Aptahem AB (publ)

Norra Vallgatan 58, 4TR
Malmö 211 22
Sweden
46 7 66 02 01 99
https://www.aptahem.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 5

Key Executives

NameTitlePayExercisedYear Born
Dr. Bert JunnoCo-Founder & Chairman of the BoardN/AN/A1966
Mr. Mikael LindstamCo-Founder, CEO & DirectorN/AN/A1966
Dr. Luiza JedlinaCo-Founder & CSON/AN/AN/A
Mr. Ola SkanungChief Financial OfficerN/AN/A1964
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Corporate Governance

Aptahem AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.